Cimetidine |
Tagamet; Tagamet HB |
Cimetidine Systematic (IUPAC) name 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl) methylsulfanyl]ethyl]guanidine Identifiers CAS number 51481-61-9 ATC code A02BA01 PubChem 2756 DrugBank APRD00568 Chemical data Formula C10H16N6S Mol. weight 252.34 g/mol Pharmacokinetic data Bioavailability 60-70% Protein binding 15-20% Metabolism Hepatic Half life 2 hours Excretion Renal Therapeutic considerations Pregnancy cat. B1 (Au), B (U.S.) Leg ...
Wikipedia - [full article]
Cimetidine Clinical Trials
- A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection
ClinicalTrials.gov Identifier: NCT00002092 - Completed
HIV Infections
- Performance of Cimetidine-Corrected MDRD Equation in Renal Transplant Patients
ClinicalTrials.gov Identifier: NCT00475059 - Recruiting
Kidney Transplantation
- Biological Therapy in Treating Patients With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00002733 - Active, not recruiting
Stage IV Melanoma; Stage IV Renal Cell Cancer; unspecified adult solid tumor, protocol specific
- Study of an Oral Tyrosine Kinase Inhibitor of VEGFR-2 for the Treatment of Advanced Stage Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00074854 - Completed
Lung Cancer; Carcinoma, Non-Small-Cell Lung
- Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00002922 - Completed
stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...

Not Signed In -


